The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2024

Filed:

Aug. 27, 2021
Applicant:

Boston Medical Center Corporation, Boston, MA (US);

Inventors:

Steven C. Borkan, Medfield, MA (US);

Zhiyong Wang, Cambridge, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61P 9/10 (2006.01); A61P 13/12 (2006.01); G01N 33/50 (2006.01); G01N 33/543 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4703 (2013.01); A61K 9/0019 (2013.01); A61P 9/10 (2018.01); A61P 13/12 (2018.01); C07K 14/47 (2013.01); G01N 33/5091 (2013.01); G01N 33/54306 (2013.01); G01N 33/6875 (2013.01); C07K 2319/09 (2013.01); G01N 2440/14 (2013.01); G01N 2800/347 (2013.01);
Abstract

One aspect of the technology relates to methods, assays and kits to identify ischemia and ischemic injury, including kidney injury, and are useful in determining efficacy of cancer treatments. In particular, differential phosphorylation of the nucleophosmin (NPM) polypeptide is an early marker of ischemic injuries such as kidney injury, AKI and ischemic renal cell injury. Another aspect of the technology relates to compositions and methods for the treatment of ischemia and kidney injury, including NPM inhibitory agents, including, but not limited to NPM inhibitory peptides for the treatment of ischemia and kidney injury.


Find Patent Forward Citations

Loading…